Addressing a Blind Spot in Treatments for the Cornea

Clarke Atwell, CEO of Claris Bio, discusses the cornea, the role hepatocyte growth factor plays in its healing, and the rare and chronic condition neurotrophic keratitis that it is focusing on as its lead indication.